Bank Of New York Mellon Corp Matinas Bio Pharma Holdings, Inc. Transaction History

Bank Of New York Mellon Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.46 - $42.69 $76,203 - $7.07 Million	165,659 New	165,659 $82,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $0.96 $2,022 - $3,082	-3,211 Reduced 1.89%	166,249 $131,000
Q2 2021 Aug 11, 2021	SELL	$0.75 - $1.1 $10,475 - $15,363	-13,967 Reduced 7.61%	169,460 $132,000
Q1 2021 May 13, 2021	SELL	$0.96 - $1.74 $15,455 - $28,012	-16,099 Reduced 8.07%	183,427 $192,000
Q1 2020 May 06, 2020	BUY	$0.6 - $2.31 $26,980 - $103,876	44,968 Added 29.09%	199,526 $119,000
Q2 2019 Aug 12, 2019	BUY	$0.79 - $1.11 $77,815 - $109,336	98,501 Added 175.72%	154,558 $132,000
Q1 2019 May 14, 2019	SELL	$0.6 - $1.41 $1,008 - $2,370	-1,681 Reduced 2.91%	56,057 $61,000
Q2 2018 Aug 06, 2018	SELL	$0.42 - $0.74 $50,026 - $88,142	-119,111 Reduced 67.35%	57,738 $25,000
Q1 2018 May 15, 2018	BUY	$0.76 - $1.32 $1,158 - $2,011	1,524 Added 0.87%	176,849 $135,000
Q4 2017 Feb 09, 2018	BUY	$1.1 - $1.54 $192,857 - $270,000	175,325	175,325 $203,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.